Updated 20 April 2022
Newmedica Community Ophthalmology Service is operated by Gloucestershire Newmedica Limited. The service has been operating since 15 September 2017.
Gloucestershire Newmedica Limited is a partly owned local operating subsidiary of New Medical Systems Limited. New Medical Systems Limited is owned by Specsavers Eye Care Services Limited.
New Medical Systems Limited and its partly owned local operating subsidiaries are referred to as The Newmedica Group.
The Newmedica Group is commissioned by NHS organisations to provide ophthalmology services (clinical eye care) to people who are patients being treated by the NHS. The service also offers private patients access to services which accounts for around 5% of their overall activity.
The service provides ophthalmic surgery and outpatient care from Aspen Centre, Horton Road, Gloucester, GL1 3PX. The service primarily serves the communities of the South West.
The service is registered with the Care Quality Commission to provide the following regulated activities:
- Diagnostic and screening procedures
- Surgical procedures
- Treatment of disease, disorder or injury.
All surgery undertaken by the service is adult, day case, ophthalmology surgery. The majority of the service is provided for NHS funded patients. All surgery is undertaken under local anaesthesia. There are no overnight patient stays.
The provider has another location, Newmedica Brighouse, also in Gloucester, this is the main theatre site. The theatre at Aspen Centre is used for additional theatre space and is used on average one day a week. Since September 2022 outpatient appointments are also carried out at Swindon NHS Health Centre. They have identified this as a satellite clinic. We did not inspect these services as part of this inspection.
A manager had been registered with the CQC since 2017. The location was first registered in September 2017. This was our first inspection of this location.
In the reporting period from 1 February 2021 to 31 January 2022 1,585 operations were undertaken within the location; approximately 1,400 of these operations were cataract removal.
In the same period there were 4,119 follow up outpatient appointments and 1,356 new outpatient appointments. The majority of these patients were seen as part of the cataract surgery pathway or glaucoma treatment.
The main service provided at this location was surgery with the majority of outpatient appointments being provided as part of the surgical pathway. Where our findings for outpatients, for example management arrangements, also apply to other services, we do not repeat the information but cross-refer to the surgery section.